NATIONAL HEALTHCARE CORP
Business
National HealthCare Corporation operates skilled nursing facilities, assisted living facilities, independent living facilities, homecare and hospice agencies, and behavioral health hospitals across 9 states, primarily in the Southeast and Midwest. The company provides sub-acute and post-acute skilled nursing care, rehabilitative services, memory care, senior living, home health, hospice, and behavioral health services, along with management and accounting services to third-party operators. Operating segments include inpatient services (skilled nursing, assisted and independent living, behavioral health) and homecare and hospice services, with revenues primarily from Medicare, Medicaid, managed care, and private pay sources.
Summary from 10-K filed 2026-02-26
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Net patient revenues | 1,470 | 1,252 | 1,088 | 1,029 | 966 | |
| Other revenues | 48 | 46 | 54 | 45 | 45 | |
| Government stimulus income | 0 | 9 | 0 | 11 | — | |
| Net operating revenues and stimulus income | 1,518 | 1,307 | 1,142 | 1,086 | 1,074 | |
| Salaries, wages and benefits | 921 | 811 | 712 | 686 | 666 | |
| Other operating | 377 | 321 | 288 | 289 | 267 | |
| Facility rent | 46 | 43 | 42 | 41 | 41 | |
| Depreciation and amortization | 45 | 42 | 42 | 40 | 41 | |
| Total costs and expenses | 1,389 | 1,217 | 1,084 | 1,054 | 1,023 | |
| Income from operations | 128 | 90 | 57 | 32 | 51 | |
| Non-operating income | 18 | 20 | 17 | 11 | 18 | |
| Interest expense | −6 | −4 | −324,000 | — | — | |
| Unrealized gains on marketable equity securities | 22 | 31 | 15 | −16 | −14 | |
| Income before income taxes | 162 | 136 | 89 | 27 | — | |
| Income tax provision | −40 | −34 | −23 | −7 | −11 | |
| Net income | 123 | 102 | 65 | 20 | 139 | |
| Net (income) loss attributable to noncontrolling interest | −3 | −159,000 | 2 | 2 | −497,000 | |
| Net income attributable to National HealthCare Corporation | 120 | 102 | 67 | 22 | 139 | |
| Basic (in dollars per share) | 7.76 | 6.62 | 4.36 | 1.46 | 9.03 | |
| Diluted (in dollars per share) | 7.67 | 6.53 | 4.34 | 1.45 | 8.99 | |
| Basic (in shares) | 15 | 15 | 15 | 15 | 15 | |
| Diluted (in shares) | 16 | 16 | 15 | 15 | 15 | |
| Dividends declared per common share (in dollars per share) | 2.53 | 2.42 | 2.34 | 2.26 | 2.11 |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2024 2024-09-30 | FY 2023 2023-12-31 | FY 2022 2022-12-31 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 93 | 76 | — | 107 | 59 | |
| Restricted cash and cash equivalents, current portion | 18 | 20 | — | 18 | 15 | |
| Marketable equity securities | 163 | 140 | — | 111 | 101 | |
| Restricted marketable equity securities | 17 | 23 | — | 27 | 22 | |
| Restricted marketable debt securities, current portion | 18 | 12 | — | 13 | 16 | |
| Accounts receivable | 139 | 135 | — | 109 | 100 | |
| Inventories | 8 | 9 | — | 7 | 7 | |
| Prepaid expenses and other assets | 6 | 10 | — | 9 | 10 | |
| Total current assets | 462 | 424 | — | 406 | 354 | |
| Property and equipment, gross | 1,309 | 1,282 | — | 1,102 | 1,081 | |
| Less: Accumulated depreciation | −635 | −597 | — | −608 | −575 | |
| Net property and equipment | 674 | 684 | — | 493 | 507 | |
| Restricted cash and cash equivalents, less current portion | 1 | 1 | — | 1 | 1 | |
| Restricted marketable debt securities, less current portion | 105 | 108 | — | 109 | 103 | |
| Deposits and other assets | 7 | 9 | — | 15 | 13 | |
| Operating lease right-of-use assets | 48 | 79 | — | 94 | 121 | |
| Goodwill | 170 | 170 | — | 168 | 168 | |
| Intangible assets | 20 | 20 | — | 7 | 7 | |
| Investments in unconsolidated companies | 39 | 28 | — | 16 | 2 | |
| Total other assets | 391 | 416 | — | 411 | 415 | |
| Total assets | 1,526 | 1,524 | — | 1,311 | 1,275 | |
| Trade accounts payable | 23 | 25 | — | 19 | 17 | |
| Operating lease liabilities, current portion | 34 | 32 | — | 29 | 29 | |
| Accrued payroll | 104 | 93 | — | 84 | 73 | |
| Amounts due to third party payors | 14 | 15 | — | 18 | 17 | |
| Accrued risk reserves, current portion | 36 | 31 | — | 31 | 31 | |
| Other current liabilities | 26 | 21 | — | 23 | 18 | |
| Dividends payable | 10 | 9 | — | 9 | 9 | |
| Long-term debt due within one year | 8 | 8 | 8 | 0 | — | |
| Total current liabilities | 254 | 235 | — | 214 | 198 | |
| Long-term debt, less current portion | 33 | 130 | 130 | 0 | — | |
| Operating lease liabilities, less current portion | 13 | 46 | — | 63 | 91 | |
| Accrued risk reserves, less current portion | 85 | 73 | — | 73 | 71 | |
| Refundable entrance fees | 6 | 6 | — | 6 | 6 | |
| Deferred income taxes | 43 | 36 | — | 17 | 11 | |
| Other noncurrent liabilities | 18 | 17 | — | 26 | 20 | |
| Total liabilities | 452 | 541 | — | 400 | 398 | |
| Common stock, $.01 par value; 45,000,000 shares authorized; 15,536,427 and 15,450,003 shares, respectively, issued and outstanding | 155,000 | 154,000 | — | 153,000 | 153,000 | |
| Capital in excess of par value | 236 | 233 | — | 228 | 227 | |
| Retained earnings | 833 | 752 | — | 688 | 657 | |
| Accumulated other comprehensive loss | −779,000 | −5 | — | −7 | −10 | |
| Total National HealthCare Corporation stockholders equity | 1,069 | 980 | — | 909 | 874 | |
| Noncontrolling interest | 6 | 3 | — | 2 | 3 | |
| Total equity | 1,075 | 983 | — | 910 | 878 | |
| Total liabilities and equity | 1,526 | 1,524 | — | 1,311 | 1,275 |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Depreciation and amortization | 45 | 42 | 42 | 40 | 41 | |
| Equity in earnings of unconsolidated investments | −218,000 | −589,000 | −2 | −477,000 | −5 | |
| Distributions from unconsolidated investments | 616,000 | 512,000 | 470,000 | 439,000 | 6 | |
| (Gains) losses on sale of marketable securities | −1 | −1 | 667,000 | 1 | −1 | |
| Gain on sale of unconsolidated company | 0 | −1 | 0 | 0 | — | |
| Gain on sale of property and equipment | −4 | 0 | −6 | — | — | |
| Deferred income taxes | −6 | −18 | −6 | −6 | 6 | |
| Stockbased compensation | 4 | 4 | 3 | 3 | 3 | |
| Accounts receivable | −4 | −26 | −9 | −4 | 4 | |
| Inventories | 1 | −599,000 | −298,000 | 1 | 199,000 | |
| Prepaid expenses and other assets | 5 | 6 | −669,000 | −11 | −3 | |
| Operating lease obligations | 695,000 | 273,000 | −1 | −430,000 | 0 | |
| Trade accounts payable | −3 | 6 | 2 | −6 | −2 | |
| Accrued payroll | 11 | 5 | 12 | −34 | 17 | |
| Amounts due to third party payors | −2 | −3 | 2 | −964,000 | 649,000 | |
| Accrued risk reserves | 18 | 357,000 | 790,000 | 4 | −1 | |
| Other current liabilities | 5 | −3 | 5 | −2 | −1 | |
| Other noncurrent liabilities | 1 | −10 | 6 | 3 | −12 | |
| Net cash provided by operating activities | 185 | 107 | 111 | 9 | 62 | |
| Purchases of property and equipment | −36 | −28 | −28 | −30 | −39 | |
| Investments in unconsolidated companies | −6 | −14 | −5 | 0 | −350,000 | |
| Purchases of marketable securities | −65 | −35 | −30 | −34 | −108 | |
| Sale of marketable securities | 73 | 52 | 47 | 50 | — | |
| Collections of (investments in) notes receivable | 512,000 | −9,000 | −201,000 | 4 | 9 | |
| Proceeds from sale of assets | 0 | 2 | 0 | 4 | 0 | |
| Net cash used in investing activities | −34 | −237 | −18 | −6 | −66 | |
| Borrowings under credit facility | 0 | 150 | 0 | 0 | 0 | |
| Repayments under credit facility | −97 | −13 | 0 | 0 | 0 | |
| Dividends paid to common stockholders | −39 | −37 | −36 | −35 | −32 | |
| Issuance of common shares | 14 | 14 | 313,000 | 2 | 3 | |
| Repurchase of common shares | −15 | −14 | −2 | −10 | −836,000 | |
| Noncontrolling interest contributions | 150,000 | 1 | 0 | 250,000 | −964,000 | |
| Entrance fee deposits (refunds) | 115,000 | −313,000 | 169,000 | −804,000 | −452,000 | |
| Debt issuance costs | 0 | −400,000 | 0 | 0 | — | |
| Principal payments under finance lease obligations | 0 | −860,000 | −5 | −5 | −4 | |
| Net cash (used in) / provided by financing activities | −136 | 100 | −43 | −48 | −35 | |
| Net Increase (Decrease) in Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents | 15 | −29 | 51 | −45 | −39 | |
| Cash payments for interest | 7 | 3 | 290,000 | 493,000 | 845,000 | |
| Cash payments for income taxes | 25 | 18 | 15 | 9 | 23 |
Filings
Material Events
Insiders
Institutional Holders
Frequently asked questions
What is NATIONAL HEALTHCARE CORP's CIK number?
NATIONAL HEALTHCARE CORP's SEC CIK number is 0001047335 (1047335). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.
Where can I find NATIONAL HEALTHCARE CORP's SEC filings?
All of NATIONAL HEALTHCARE CORP's EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.
When did NATIONAL HEALTHCARE CORP last report earnings?
NATIONAL HEALTHCARE CORP (NHC) most recently filed an earnings 8-K with the SEC on May 8, 2026, furnishing its results under Item 2.02 (Results of Operations and Financial Condition). The earnings press release is attached to that filing (accession 0001437749-26-015802). This is NATIONAL HEALTHCARE CORP's most recent earnings filing of record — not a forecast of its next earnings date.
What is NATIONAL HEALTHCARE CORP's most recent earnings 8-K?
NATIONAL HEALTHCARE CORP's latest earnings 8-K (Item 2.02) was filed May 8, 2026 under accession 0001437749-26-015802. It carries the quarterly or annual earnings press release — the earliest official, SEC-filed version of the results.
View NATIONAL HEALTHCARE CORP's latest earnings 8-K →
Look up any company's CIK number →